Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405659 | PMC |
| http://dx.doi.org/10.1002/ctm2.70437 | DOI Listing |
Publication Analysis
Top Keywords
pcdhgb7 inhibits
4
inhibits progression
4
progression triple-negative
4
triple-negative breast
4
breast cancer
4
cancer suppressing
4
suppressing xrcc5/myc-mediated
4
xrcc5/myc-mediated ribosome
4
ribosome biogenesis
4
pcdhgb7
1
Similar Publications
PCDHGB7 inhibits the progression of triple-negative breast cancer by suppressing XRCC5/MYC-mediated ribosome biogenesis.
Clin Transl Med
September 2025
Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
PCDHGB7 Increases Chemosensitivity to Carboplatin by Inhibiting HSPA9 via Inducing Apoptosis in Breast Cancer.
Dis Markers
January 2020
Department of Pathology, Basic Medical Science College, Harbin Medical University, Harbin, China.
Breast cancer is one of the most serious cancers worldwide, and chemotherapy resistance frequently drives cancer progression. Triple-negative breast cancer (TNBC) has a high recurrence rate and poor prognosis given its resistance to chemotherapy. In our previous study, we found a remarkable abnormal methylation modification of the PCDHGB7 gene in breast cancer.
View Article and Find Full Text PDF